If you start seeing that youre getting overpaid.

Food and Drug Administration; the agency is expected to make a decision early next month.the first medicine licensed using the gene editing tool CRISPR.

and is also more common in certain ethnic groups.Vertex Pharmaceuticals said it had not yet established a price for the treatment in Britain and was working with health authorities to secure reimbursement and access for eligible patients as quickly as possible.the genetic mutation can cause severe anemia.

have been the only long-lasting treatment.The use of the word cure in relation to sickle cell disease or thalassemia has.

but a report by the nonprofit Institute for Clinical and Economic Review said prices up to around $2 million would be cost-effective.

Scientists believe being a carrier of the sickle cell trait helps protect against severe malaria.the first medicine licensed using the gene editing tool CRISPR.

Patients first receive a course of chemotherapy.research earlier this year showed medical expenses for current sickle cell treatments.

calling the MHRAs approval of gene therapy a positive moment in history.The use of the word cure in relation to sickle cell disease or thalassemia has.